Actively Recruiting
Treatment of Chronic Pelvic Pain Due to Endometriosis by Transcutaneous Auricular Vagus Nerve Stimulation
Led by Hopital Foch · Updated on 2025-11-21
72
Participants Needed
1
Research Sites
275 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
6-10% of women of childbearing age suffer from endometriosis, which is mainly manifested by dysmenorrhea, non-menstrual pelvic pain and dyspareunia. Several treatment strategies, including surgical ones, are proposed but they are sometimes insufficient because endometriosis-related pain is frequently accompanied by sensitization. Endometriosis surgery, when indicated, is therefore changeably effective, even though the lesions have been completely resected. Patients therefore consult Pain Units seeking for the effective treatment as the pain persist even after surgical management of endometriosis. Vagus nerve stimulation is a non-invasive technique that includes an anti-inflammatory effect and a modulation of neurotransmitter production (adrenaline, norepinephrine; serotonin, acetylcholine). Yuan and Silberstein published a general review on the technique. Migraine and depression are one of the selected indications. In addition, Napadow et al. published favourable results in a short series of patients with chronic pelvic pain. The Investigators of this study have treated some patients with this technique with a result deemed satisfactory which leads to propose a randomized study to confirm this impression.
CONDITIONS
Official Title
Treatment of Chronic Pelvic Pain Due to Endometriosis by Transcutaneous Auricular Vagus Nerve Stimulation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 6 15 years
- Experiencing chronic pelvic pain and/or painful periods and/or pain during intercourse
- Receiving care from a gynecologist at a participating study center
- Diagnosed with endometriosis
- Provided signed informed consent
- Covered by a health insurance plan
You will not qualify if you...
- Contraindications to transcutaneous auricular vagus nerve stimulation such as heart conditions or asthma
- Pregnant or breastfeeding women
- Patients undergoing in vitro fertilization
- Having other conditions that require long-term pain medication
- Received vagus nerve stimulation treatment within 12 months prior to joining
- Individuals deprived of liberty or under guardianship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hopital Foch
Suresnes, Île-de-France Region, France, 92150
Actively Recruiting
Research Team
M
Mireille MICHEL-CHERQUI, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here